Document Page: First | Prev | Next | All | Image | This Release | Search
File: 061796_DOC_125_Investigational_New_Drug_Availability_04.txt
II~~I~~~I~,1MS~II2M~IITh1I1IIIIIII'££~Jz
ROUTINE U N C L ~ S S J F I E D I TOD =
11IIZII11XMMIWIIII)kIZJIIII1III1IIIZ~ I
P~OE ()3 RHIP~~~\\\\ UNCt.~S
Ic)-6~~A)
4. CONCEPT OF UTiI.I~~TION: RE~JEST TH~T F:~C~ILITIES
INTERESTED IN UTILI~~TION OF THESE INnS ~PPOINT POINTS OF
CONT~CT - PREFER~BLY ~ CLINICISN WITH SOME INTEREST OR
B~CKGROLiND IN INTENSIVE C~RE OR IN~ECTIOlJS DISE~SES - TH~T
WILL F~MILI~PI2E THEMSELVES WITH THE INVESTIG~TiONAL PROTOCOLS
~ND COMPLETE THE ONE P4(3E THER~PY EV~LtJ~TION FORMS (TFr)
PROVIDED WITH THE PROTOCOL. SUGGEST TH~T THE CENTOXIN BE
LIMITED TO F~CILITIES WITH 400 BEDS OR MORE: ~Nfl BE LJMITED IN
THE INITI4L DISTRIBliTION TO FOUR VJ~LS WITH RESUPPLV DEPENDENT
ON ~V~IL~BILITY OF ~fl£)ITION~L SUPPLIES SUIjOEST TH~T THE
RIB~YIRIN BE SUFFICIENT FOR ONE INTR~VENOtJS COLiRSE OF THER~PY
BE PROVIDED TO ~LL INP~TIENT TRE~TMENT F~C1LIT~ES ~JD HOLD 4LL
OR~L COLIRSES ~T THE MEDIC~L StiPPLY F~CILITY IN ~N ON-C~LL
ST~TLJS.
9. PLE~SE PROVIDE THE N~MES ~ND ME~NS OF CONT~CT FOR pocas
THROUGH COMPONENT SLIRGEONS TO THE CENTCOM SlJRGEON'S OFrICE.
6. POINTS OF CONT~CT: CENTCOM StJRflEONS OFFICE. OR
~T ~~6-1-477-819() f)R T~CTIC~L 9-~969-769; THE~TER
N~VV POC. N~VY FOR~~RD L~B ~r 9~6-3-341-c)1~3 OR C:DR
P~GE O4 RHIPA4~\\\\ tJNCL~~S
~~ COMUSNSVLD(3SlJPFOR/N-- 9 ~T 9~73-72B-B77; THE~TE.R
~RMV POC: COL PREVENTIVE MED:tCINE CONSULT~NT COMM
O11-966-1-49F3-S4B9. MEUSOM POC ~. 966-3-857-4191 OR
T~C q-7E3(~-~~1 ,/
BT
#2433
NNNN
~IIII~L.ZKL.IIIMzIIMxKI, ~IIKKMIIIIIIWXI
ROUTINE U N C L ~ S S I F I E 0 1
IiI~L~IIIIIII~IIIIXIII IIII~IIZ1Ii~IIi
Document Page: First | Prev | Next | All | Image | This Release | Search